Adelman AS, McLaughlin CC, Wu X-C, Chen VW, and Groves FD (2005) Urbanisation and incidence of acute lymphocytic leukaemia among United States children aged 0-4. British Journal of Cancer 92:2084-2088.
American Cancer Society. The History of Cancer. http://www.cancer.org/docroot/CRI/content/CRI_2_6x_the_history_of_cancer_72.asp?sitearea=CRI
Askling J, Brandt C, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, and Ekbom A (2005) Risk of haematopoietic cancer in patients with inflamatory bowel disease. Gut 54:617-22.
Berger U, Maywald O, Pfirrmann M, LaHaye T, Hochlaus A, Reiter A, Hasford J, Heimpel H, Hossfeld DK, Kolb H-J, Loffler H, Pralle H, Queisser W, and Hehlmann R (2005) Gender aspects in chronic myeloid leukemia: long term results from randomized studies. Leukemia 19:984-989.
Biondi A, Cimino G, Pieters R, and Ching-Hon P (2000) Biological and theraputic aspects of infant leukemia. Blood 96:24-33.
Bowden ME (2002) Pharmaceutical Achievers. Philadelphia: Chemical Heritage Foundation.
Burns SB (2004) Quackery and cancer cures - A Pictorial of Healing: Clinician Reviews.http://www.findarticles.com/p/articles/mi_m0BUY/is_3_14/ai_114981865#continue
Caporaso N, Marti GE, and Goldin L (2004) Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Seminars in Hematology 41:201-6.
Forestier R, Johansson B, Borgstrom G, Kerndrup G, Johansson J, Heim S, and Group tNLCS (2000) Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. European Journal of Haematology 64:194-200.
Geologia African Sunset. http://www.geologia.com/foto/africa13.jpg
Gilham C, Peto J, Simpson J, Roman E, Eden TO, Greaves MF, and Alexander FE (2005) Day care in infancy and risk of childhood acute lymphoblastic leukemia: findings from UK case-control study. British Medical Journal 330:1294.
Giunta J (1998) Oral Pathology: Case 76.http://www.forsyth.org/oralpathology/case_076_answer.htm
Goldman JM (2003) Monitoring and Management of CML. Medscape.http://www.medscape.com/viewprogram/2213_pnt
Greaves M (2000) Cancer: The Evolutionary Legacy. Oxford: Oxford University Press.
Greaves MF (1999) Molecular genetics, natural history and the demise of childhood leukemia. European Journal of Cancer 35:173-85.
Greaves MF, Colman SM, Beard MEJ, Bradstock K, Cabrera ME, Chen P-M, Jacobs P, Lam-Po-Tang PRL, MacDougall LG, Williams CKO, and Alexander FE (1993) Geographical Distribution of Acute Lymphoblastic Leukemia Subtypes: Second Report of the Collaborative Group Study. Leukemia 7:27-34.
Greaves MF, Maia AT, Wiemels JL, and Ford AM (2003) Leukemia in twins: lessons in natural history. Blood 102:2321-2333.
Health Related Pictures and Definitions. http://health-pictures.com/leukemia-cutis.htm
Huntley BJP, and Gilliland DG (2005) Leukemia stem cells and the evolution of cancer-stem-cell research. Nature Reviews. Cancer 5:311-21.
Imaginis History of Radiation Therapy. http://imaginis.com/radiotherapy/radio_history.asp
Institute of Cancer Research History. http://www.icr.ac.uk/ieu/about_us/history/history3.htm
Janeway CA, Travers P, Walport M, and Capra JD (1999) Immuno-Biology The Immune System in Health and Disease: Elsevier Science Ltd/ Garland Publishing.
Klatt EC, Garff J, and Dennis SE (1994) Hematopathology. http://www.md.huji.ac.il/mirror/webpath/HEME.html
Kussick SJ, and Wood BL (2001) Case: Bilineage T-lymphoblastic and Myeloid Blast Transformation of Chronic Myelogenous Leukemia. http://www.flowcases.org/casebuilder/index.cfm?fuseaction=displayCase2&caseID=51
Leukemia and Lymphoma Society (2005) Leukemia.http://www.leukemia-lymphoma.org/all_page?item_id=7026
Marley SB, and Gordon MY (2005) Chronic myeloid leukemia: stem cell derived but progenitor cell driven. Clinical Science 109:13-25.
Motoiu IR, Pecek M, Dumitrescu A, Colita A, Necula A, Moldoveanu E, and Colita D (1993a) Introduction to the Study of Adult T-cell Leukemia and HTLV-1 Sero-Positivity in Romania. Rev. Roum. Med. INt. 31:199-205.
National Cancer Institute Leukemia.http://www.cancer.gov/cancertopics/types/leukemia
National Cancer Institute (2002) Acute Lymphoblastic Leukemia in Children: Questions and Answers.http://www.cancer.gov/cancertopics/factsheet/ALLinchildren
Oncology Channel (1998) Leukemia.http://www.oncologychannel.com/leukemias/symptoms.shtml
Pui C-H (2003) About Leukemia - Historical Perspectives: Childhood Leukemias.http://www.stjude.org/search/0,2616,582_3161_3786,00.html
Ries LMG, Smith MA, Gurney JG, and Ross JA (1999) "Leukemia" in Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. National Institute of Health Publication 99.
Robien K, and Ulrich CM (2003) 5, 10-Methylenetetrahydrofolate Reductase Polymorphisms and Leukemia Risk. American Journal of Epidemology 157:571-82.
Rosenbaum P, Buck G, and Brecher M (2005) Allergy and infectious disease histories and the risk of childhood acute lyphoblastic leukaemia. Pediatric and Perinatal Epidemiology 19:152-64.
Ross D (2000) Novel mechanisms of drug resistance in leukemia. Leukemia
Sompayrac L (1999) How the Immune System Works: Blackwell Science.
Swerdlow SH, Habeshaw JA, Rohatiner AZS, Lister TA, and Stansfeld AG (1984) Caribbean T-cell lymphoma/leukemia. Cancer 54:687-96.
St. Jude’s Research Hospital (2005) St. Jude Patients and Martha Pullen Sewing Family Originals. http://www.stjude.org/
Taub JW, and Ge Y (2004) The prenatal origin of childhood acute lymphoblastic leukemia. Leukemia & Lymphoma 45:19-25.
Toren A, Rechavi G, and Ramot B (1996) Pediatric Cancer: Enviromental and Genetic Aspects. Pediatric Hematology and Oncology 13:319-331.
Tracey MC, and Carter JM (2005) Ethnicity Variables in the Incidence Rates of Leukemia in New Zealand Populations: Implications for Stem-Cell Transplantation. American Journal of Hematology 79:114-118.
Wadsworth Center for Clinical Chemistry and Hematology.http://www.wadsworth.org/chemheme/heme/microscope/all.htm
Waxman S, and Anderson KC (2001) History of the Development of Arsenic Derivatives in Cancer Therapy. The Oncologist 6:3-10.